---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-219617"
form_type: "8-K"
ticker: "BCAX"
cik: "0002023658"
company_name: "Bicara Therapeutics Inc."
filed_at: "2024-09-16T23:59:59+00:00"
generated_at: "2026-05-31T04:46:55.103620+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Bicara Therapeutics files amended charter and bylaws post-IPO, increases authorized shares to 500M

## Summary
- Authorized 500 million shares of common stock and 10 million shares of undesignated preferred stock.
- Eliminated stockholder ability to act by written consent and to call special meetings.
- Established advance notice procedures for stockholder proposals and director nominations.
- Amendments effective immediately prior to completion of IPO, as previously disclosed in S-1.

## SEC filing metadata
- accession: 0001193125-24-219617
- form_type: 8-K
- ticker: BCAX
- cik: 0002023658
- company_name: Bicara Therapeutics Inc.
- filed_at: 2024-09-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2023658/000119312524219617/0001193125-24-219617-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2023658/000119312524219617/d844648d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-219617
- JSON: https://secwatch.observer/filing/0001193125-24-219617.json
- Plain text: https://secwatch.observer/filing/0001193125-24-219617.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.